Boston Scientific Corp (BSX) stock saw a decline, ending the day at $100.31 which represents a decrease of $-0.60 or -0.59% from the prior close of $100.91. The stock opened at $100.91 and touched a ...

The results will support the company’s application for expanded labeling of its popular Farapulse pulsed field ablation ...

We recently published a list of Billionaire Steve Cohen’s Top 15 Stock Picks. In this article, we are going to take a look at ...

Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $98.66 which represents a slight increase of $0.49 or 0.50% from the prior close of $98.17. The stock opened at $97.93 and ...

In August, a single email triggered a chain of hand-wringing and strategizing inside one of America’s largest medical technology companies: A reporter asked Boston Scientific if the biotech ...

US healthtech giant Boston Scientific’s pulmonary vein isolation (PVI) device trial has met its primary endpoint in patients ...

This was the stock's fifth consecutive day of gains.

Barclays raised the firm’s price target on Boston Scientific (BSX) to $111 from $86 and keeps an Overweight rating on the shares. The firm says ...

Marlborough-based Boston Scientific has entered into a definitive agreement to acquire California-based medical equipment manufacturer Bolt Medical.

Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn ...

Boston Scientific (NYSE: BSX) today reported data from separate studies backing its Farapulse and Watchman FLX systems.

Boston Scientific (BSX) announced on Wednesday the acquisition of the ~74% stake in Bolt Medical that the medical devices company does not already own.